Lv0
0 积分 2023-10-12 加入
Exploring nondegrading molecular glues for protein–protein interactions
13天前
已完结
Safety, Pharmacokinetics, and Pharmacodynamics in Healthy Volunteers Treated With GDC‐0853, a Selective Reversible Bruton's Tyrosine Kinase Inhibitor
1个月前
已完结
New Means and Challenges in the Targeting of BTK
1个月前
已完结
Remibrutinib in Chronic Spontaneous Urticaria
1个月前
已完结
Cyanide Trapping of Iminium Ion Reactive Metabolites: Implications for Clinical Hepatotoxicity
1个月前
已完结
Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton’s Tyrosine Kinase
2个月前
已完结
Remibrutinib, a Novel Bruton Tyrosine Kinase Inhibitor, Exhibits Improved Target Selectivity and Potency in Vitro
2个月前
已完结
GPCR drug discovery: new agents, targets and indications
2个月前
已完结
Disproportionately Increasing Incidence of Inflammatory Bowel Disease in Female Patients and the Elderly: An Update Analysis from the Global Burden of Disease Study 2021
2个月前
已完结
Integrative single-cell analysis of human colorectal cancer reveals patient stratification with distinct immune evasion mechanisms
2个月前
已完结
皖公网安备34019202002308
